Expansion of Topical Wound Oxygen (TWO2) Product Family Extends Treatment to Chronic Wound Patients with Larger Limbs, Venous and Diabetic Foot Ulcers

by Advanced Oxygen Therapy, Inc. | Sep 16, 2020 | Press

The addition of a new larger extremity-chamber to the company’s peripheral vascular disease (PVD) focused product line, allows for the application of TWO2 treatments for  many more patients suffering from costly nonhealing chronic wounds.

Maintain Continuity-of-Care During the COVID-19 Pandemic

by Advanced Oxygen Therapy, Inc. | Apr 17, 2020 | Press

HELPING MAINTAIN CONTINUITY-OF-CARE DURING THE COVID-19 PANDEMIC TWO2 MULTI-MODALITY TOPICAL WOUND OXYGEN THERAPY PROVIDES PROVEN HEALING & WOUND PROTECTIVE CARE SAFELY FOR YOUR PATIENTS AT HOME N Effective wound infection management helping keep patients out of...

Topical Wound Oxygen (TWO2) therapy Treats High-Risk Patients Safely at Home during the COVID-19 Pandemic

by Advanced Oxygen Therapy, Inc. | Apr 6, 2020 | Press

AOTI Inc. announced today that since the outbreak of the COVID-19 pandemic it has been focusing all its resources on supporting a growing number of wound care patients being treated at home by its unique multi-modality Topical Wound Oxygen (TWO2) therapy.

AOTI Inc.’s state of the art RCT receives editorial commentary in Diabetes Care, March 2020.

by Advanced Oxygen Therapy, Inc. | Mar 1, 2020 | In The News, Press

Read Full...

Breakthrough RCT Published in Leading ADA Journal “Diabetes Care” Shows Multi-Modality Topical Wound Oxygen (TWO2) Therapy is Six-Times More Effective Healing & Reducing Recurrence of Diabetic Foot Ulcers

by Advanced Oxygen Therapy, Inc. | Oct 16, 2019 | In The News, Press

AOTI Inc. today announced that a state-of-the-art Randomized Controlled Trial (RCT) demonstrating the efficacy of its unique multi-modality cyclical pressure Topical Wound Oxygen (TWO2) therapy in healing and reducing recurrence of Diabetic Foot Ulcers (DFU) has been...